Monopolization Claim Against 10x Should Proceed, Judge Says

Curio Bioscience Inc.'s counterclaim alleging anticompetitive conduct and monopolistic intent by 10x Genomics Inc. in a case over patented gene-expression technology should proceed, a federal magistrate judge said in a mixed report.

Magistrate Judge Christopher J. Burke’s report and recommendation, issued Wednesday in the US District Court for the District of Delaware, advised Judge Maryellen Noreika to dismiss Curio’s counterclaim accusing 10x and co-plaintiff Prognosys Biosciences Inc. of illegally conspiring to monopolize the market for spatial transcriptomics. But Curio should have a chance to fix the counterclaim’s deficiencies, he said.

Burke recommended dismissing parts of Curio’s counterclaim that alleges ...